NCT00201760 - Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 25, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Breast Cancer

Interventions

DRUG

Gemcitabine

1000 mg/m2 IV over 30 minutes on Days 1 and 8.

DRUG

Trastuzumab

2 mg/kg IV on days 1, 8 and 15. If Trastuzumab has not been administered within the 3 weeks before starting this treatment, the first dose of Trastuzumab given on Cycle 1, Day 1 will be 4 mg/kg followed by 2 mg/kg weekly.

DRUG

Cisplatin

30 mg/m2 IV on Day 1 and Day 8.

Trial Locations (1)

43210

Ohio State University, Columbus